Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05462951 · ClinicalTrials.gov registry record
Clinical Trial of Molecular Biomarkers in Women With Uterine Cervix Cancer
A clinical trial of Uterine Cervix Cancer, sponsored by Denise Fabian.
- Active
- Registry status
- 19
- Enrollment target
- 1
- Study location
NCT05462951 is a study of Uterine Cervix Cancer that is active but no longer recruiting, run by Denise Fabian. The registered enrollment target is 19 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05462951, a study of Uterine Cervix Cancer, is active but no longer recruiting, sponsored by Denise Fabian.
- ACTIVE NOT RECRUITING
- Registry status
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a phase 0 clinical trial of molecular biomarkers in women with uterine cervix cancer. Women receive standard-of-care radiochemotherapy followed by brachytherapy. Blood samples are obtained to detect circulating levels of deoxyribonucleotides, human papillomavirus DNA, and circulating tumor cells.
Conditions Studied
Interventions
- RADIATION Standard
Study Locations (1)
Kentucky
- Markey Cancer Center - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2023-01-03 |
| Est. Completion | 2026-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05462951
The ClinicalTrials.gov registry entry for NCT05462951 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Denise Fabian, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Uterine Cervix Cancer appearing as the primary indexed condition, and to 1 intervention - of which Standard is the first listed.
NCT05462951 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT05462951 about?
NCT05462951 is a clinical study titled "Clinical Trial of Molecular Biomarkers in Women With Uterine Cervix Cancer". This is a phase 0 clinical trial of molecular biomarkers in women with uterine cervix cancer. Women receive standard-of-care radiochemotherapy followed by brachytherapy. Blood samples are obtained to detect circulating levels of deoxyribonucleotides, human papillomavirus DNA, and circulating tumor c...
What is the current status of trial NCT05462951?
This trial is currently active not recruiting. The enrollment target is 19 participants. The study started on 2023-01-03. Estimated completion is 2026-06-01.
What conditions does trial NCT05462951 study?
This clinical trial studies the following conditions: Uterine Cervix Cancer.
What interventions are being tested in trial NCT05462951?
The interventions under investigation include: Standard (RADIATION).
Who is sponsoring clinical trial NCT05462951?
This trial is sponsored by Denise Fabian, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05462951 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uterine Cervix Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.